Evidence map›Paper›PMID 41972628›Full record

ArticleNanomaterials (Basel, Switzerland)2026

Intestinal Microfold Cells Play a Critical Role in the Uptake and Oral Tolerance Mediated by Lysophosphatidylserine-Containing Lipidic Nanoparticles.

Vincent Chak, Sujay Harne, Jason G Kay, Elizabeth Wohlfert, Sathy V Balu-Iyer

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vincent ChakDepartment of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, The State University of New York, 359 Pharmacy Building, Buffalo, NY 14214, USA.ORCID 0000-0002-0506-9125
Sujay HarneDepartment of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, The State University of New York, 359 Pharmacy Building, Buffalo, NY 14214, USA.
Jason G KayDepartment of Oral Biology, School of Dental Medicine, University at Buffalo, The State University of New York, Buffalo, NY 14214, USA.ORCID 0000-0001-8944-6612
Elizabeth WohlfertDepartment of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY 14214, USA.ORCID 0000-0001-7936-8614
Sathy V Balu-IyerDepartment of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, The State University of New York, 359 Pharmacy Building, Buffalo, NY 14214, USA.ORCID 0000-0002-0569-2865

Funding

Lipid mediated oral toleranceR01AI169296 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BALU-IYER, SATHY VENKAT, KAY, JASON G · 2022 to 2025
$2.3M
National Institute of Allergy and Infectious Diseases RO1 AI169296NIAID NIH HHS R01 AI169296
6 · The paper itself

Abstract

Phosphatidylserine (PS) is an anionic phospholipid that is exposed to the outer leaflet of the cell membrane during apoptosis. This PS externalization can teach the immune system to tolerate an antigen without eliciting immunological consequences. Previously, we showed that mice treated with PS nanoparticles containing single-chain PS (LysoPS) induced oral tolerance towards therapeutic proteins, whereas double-chain PS did not. These observations suggest that structural alterations of PS play a critical role in its tolerogenic potential. Given that intestinal microfold cells (M-cells) facilitate the transport of particulate antigens from the intestinal lumen to Peyer's patches (PP) for immune surveillance, we hypothesized that the failure of double-chain PS to induce tolerance may result from insufficient uptake by M-cells. The M cell-mediated uptake was investigated using in vitro and ex vivo studies and oral tolerance towards ovalbumin (OVA) was studied in M-cell-deficient mice. Consistent with this hypothesis, our data showed that LysoPS nanoparticles displayed at least a 2-fold increase in immune cell exposure and M-cell-mediated uptake compared to double-chain PS-containing nanoparticles. Importantly, LysoPS-mediated oral tolerance was absent in M cell-deficient mice with higher anti-ova antibody titers than the wild-type strain. These studies demonstrate that higher PS exposure on LysosPS nanoparticles compared to double chain could play a significant role in M cell-mediated tolerance.

Indexed as

apoptosisimmune regulationintestinal-M-cellsnanoparticleoral tolerancephosphatidylserineregulatory T cells

Identifiers

PMID41972628
PMCPMC13074963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.